3-50364912-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 3P and 3B. PM2PP2BP4_ModerateBS1_Supporting

The NM_006030.4(CACNA2D2):​c.3267C>A​(p.His1089Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,613,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

CACNA2D2
NM_006030.4 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.97
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA2D2. . Gene score misZ 2.9999 (greater than the threshold 3.09). Trascript score misZ 3.123 (greater than threshold 3.09). GenCC has associacion of gene with cerebellar atrophy with seizures and variable developmental delay, complex neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.25705466).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0000723 (11/152218) while in subpopulation NFE AF= 0.000147 (10/68038). AF 95% confidence interval is 0.0000791. There are 0 homozygotes in gnomad4. There are 7 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA2D2NM_006030.4 linkuse as main transcriptc.3267C>A p.His1089Gln missense_variant 37/38 ENST00000424201.7 NP_006021.2 Q9NY47-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA2D2ENST00000424201.7 linkuse as main transcriptc.3267C>A p.His1089Gln missense_variant 37/381 NM_006030.4 ENSP00000390329.2 Q9NY47-2
CACNA2D2ENST00000423994.6 linkuse as main transcriptc.3297C>A p.His1099Gln missense_variant 38/395 ENSP00000407393.2 C9JVC9
CACNA2D2ENST00000266039.7 linkuse as main transcriptc.3273C>A p.His1091Gln missense_variant 37/381 ENSP00000266039.3 Q9NY47-3
CACNA2D2ENST00000360963.7 linkuse as main transcriptc.3066C>A p.His1022Gln missense_variant 37/381 ENSP00000354228.3 Q9NY47-4
ENSG00000272104ENST00000606589.1 linkuse as main transcriptc.128-1385G>T intron_variant 3 ENSP00000476225.1 U3KQU4

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000120
AC:
3
AN:
249230
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135290
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000268
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000133
AC:
194
AN:
1461084
Hom.:
0
Cov.:
34
AF XY:
0.000125
AC XY:
91
AN XY:
726856
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000154
Gnomad4 OTH exome
AF:
0.000364
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152218
Hom.:
0
Cov.:
32
AF XY:
0.0000941
AC XY:
7
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000900
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.00000825
AC:
1
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Early infantile epileptic encephalopathy with suppression bursts Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpSep 12, 2022This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1089 of the CACNA2D2 protein (p.His1089Gln). This variant is present in population databases (rs781660163, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CACNA2D2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411008). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0023
.;T;.;.;.;T
Eigen
Benign
-0.030
Eigen_PC
Benign
0.089
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.83
T;T;T;T;T;T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.26
T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.8
.;.;.;.;.;L
PrimateAI
Uncertain
0.79
T
PROVEAN
Benign
0.23
N;N;N;N;N;N
REVEL
Benign
0.10
Sift
Benign
0.098
T;T;T;T;T;T
Sift4G
Benign
0.10
T;T;T;T;T;T
Polyphen
0.42, 0.30
.;.;.;.;B;B
Vest4
0.47
MutPred
0.42
Gain of disorder (P = 0.0517);.;.;.;.;.;
MVP
0.16
MPC
0.54
ClinPred
0.26
T
GERP RS
4.4
Varity_R
0.22
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs781660163; hg19: chr3-50402343; API